Preventive therapy in children exposed to Mycobacterium tuberculosis: Problems and solutions

Tropical Medicine and International Health

Volumn 17, Issue 10, 2012, Pages 1264-1273

  Rutherford, Merrin E ^a   Hill, Philip C ^a   Triasih, Rina ^b   Sinfield, Rebecca ^c   van Crevel, Reinout ^d   Graham, Stephen M ^e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c Mersey Deanery   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Child contacts; Policy practice gap; Preventive therapy; Tuberculosis

Indexed keywords

BCG VACCINE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RIFAMYCIN; RIFAPENTINE;

BACTERIUM; CHILD HEALTH; DISEASE PREVALENCE; HEALTH CARE; HEALTH POLICY; HEALTH RISK; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

BCG VACCINATION; CAREGIVER; CHILD; ENDEMIC DISEASE; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; LIVER TOXICITY; MEDICAL LITERATURE; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TUBERCULIN TEST; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

BRECHA ENTRE POLÍTICA Y PRÁCTICA; CHILD CONTACTS; CONTACTS DE L'ENFANT; LACUNE DANS LA PRATIQUE DE POLITIQUE; POLICY-PRACTICE GAP; PREVENTIVE THERAPY; TERAPIA PREVENTIVA; TRAITEMENT PRÉVENTIF; TUBERCULOSE; TUBERCULOSIS; TUBERCULOSIS: CONTACTOS: NIÑOS;

ANTITUBERCULAR AGENTS; ATTITUDE OF HEALTH PERSONNEL; CHILD; DRUG RESISTANCE; ENDEMIC DISEASES; GUIDELINE ADHERENCE; HEALTH POLICY; HUMANS; ISONIAZID; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; PUBLIC HEALTH; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84866329780     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.03053.x     Document Type: Review

References (89)

1. Alperstein G, Morgan KR, Mills K & Daniels L (1998) Compliance with anti-tuberculosis preventive therapy among 6-year-old children. Australian and New Zealand Journal of Public Health 22, 210-213.
2. American Thoracic Society, Center for Disease Control (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. A joint statement of the Amercian Thoracic Society, and the Centre for Disease Control and Prevention. American Journal of Respiratory and Critical Care Medicine 161, S221-S247.
3. Balcells ME, Thomas SL, Godfrey-Faussett P & Grant AD (2006) Isoniazid preventive therapy and risk for resistant tuberculosis. Emerging Infectious Diseases 12, 744-751.
4. Banu Rekha VV, Jagarajamma K, Wares F, Chandrasekaran V & Swaminathan S (2009) Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis. The International Journal of Tuberculosis and Lung Disease 13, 1507-1512.
5. Bassett IV, Wang B, Chetty S et al. (2010) Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clinical Infectious Diseases 51, 823-829.
6. Becerra MC, Pachao-Torreblanca IF, Bayona J et al. (2005) Expanding tuberculosis case detection by screening household contacts. Public Health Reports 120, 271-277.
7. Bell JC, Rose DN & Sacks HS (1999) Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective. AIDS 13, 1549-1556.
8. Bergamini BM, Losi M, Vaienti F et al. (2009) Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 123, e419-e424.
9. Biddulph J (1990) Short course chemotherapy for childhood tuberculosis. The Pediatric Infectious Disease Journal 9, 794-801.
10. Bright-Thomas R, Nandwani S, Smith J et al. (2010) Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children. Archives of Disease in Childhood 95, 600-602.
11. Bucher HC, Griffith LE, Guyatt GH et al. (1999) Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 13, 501-507.
12. Cain KP, Mccarthy KD, Heilig CM et al. (2010) An algorithm for tuberculosis screening and diagnosis in people with HIV. New England Journal of Medicine 362, 707-716.
13. Carey JW, Oxtoby MJ, Nguyen LP et al. (1997) Tuberculosis beliefs among recent Vietnamese refugees in New York State. Public Health Reports 112, 66-72.
14. Cass AD, Talavera GA, Gresham LS, Moser KS & Joy W (2005) Structured behavioral intervention to increase children's adherence to treatment for latent tuberculosis infection. The International Journal of Tuberculosis and Lung Disease 9, 415-420.
15. Cegielski JP & Mcmurray DN (2004) The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. The International Journal of Tuberculosis and Lung Disease 8, 286-298.
16. Chintu C, Mudenda V, Lucas S et al. (2002) Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 360, 985-990.
17. Claessens NJ, Gausi FF, Meijnen S et al. (2002) Screening childhood contacts of patients with smear-positive pulmonary tuberculosis in Malawi. The International Journal of Tuberculosis and Lung Disease 6, 362-364.
18. Cook PP, Maldonado RA, Yarnell CT et al. (2006) Safety and completion rate of short-course therapy for treatment of latent tuberculosis infection. Clinical Infectious Diseases 43, 271-275.
19. Diel R, Nienhaus A & Schaberg T (2005) Cost-effectiveness of isoniazid chemoprevention in close contacts. European Respiratory Journal 26, 465-473.
20. Donald PR (2010) Hepatotoxicity of Antituberculosis Agents in Children: A Literature Review Department of Paediatrics and Child Health and Division of Molecular Biology and Human Genetics and the MRC Centre for Molecular and Cellular Biology, DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences, University of Stellenbosch and Tygerberg Children's Hospital, Matieland, South Africa.
21. Du Preez K, Hesseling AC, Mandalakas AM, Marais BJ & Schaaf HS (2011) Opportunities for chemoprophylaxis in children with culture-confirmed tuberculosis. Annals of Tropical Paediatrics 31, 301-310.
22. Dye C & Williams BG (2008) Eliminating human tuberculosis in the twenty-first century. Journal of the Royal Society, Interface 5, 653-662.
23. Ena J & Valls V (2005) Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clinical Infectious Diseases 40, 670-676.
24. Ferebee S, Mount FW & Anastasiades A (1957) Prophylactic effects of isoniazid on primary tuberculosis in children; a preliminary report. American Review of Tuberculosis 76, 942-963.
25. Finnell SM, Christenson JC & Downs SM (2009) Latent tuberculosis infection in children: a call for revised treatment guidelines. Pediatrics 123, 816-822.
26. Frydenberg AR & Graham SM (2009) Toxicity of first-line drugs for treatment of tuberculosis in children: review. Tropical Medicine & International Health 14, 1329-1337.
27. Gao XF, Wang L, Lui GJ et al. (2006) Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis. The International Journal of Tuberculosis and Lung Disease 10, 1080-1090.
28. Getahun H, Kittikraisak W, Heilig CM et al. (2011) Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Medicine 8, e1000391.
29. Gomes VF, Andersen A, Wejse C et al. (2011) Impact of tuberculosis exposure at home on mortality in children under 5years of age in Guinea-Bissau. Thorax 66, 163-167.
30. Gupta A, Chandrasekhar A, Gupte N et al. (2011) Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis. Clinical Infectious Diseases 53, 1015-1018.
31. Harries AD, Hargreaves NJ, Graham SM et al. (2002) Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes. The International Journal of Tuberculosis and Lung Disease 6, 424-431.
32. Hesseling AC, Cotton MF, Jennings T et al. (2009) High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clinical Infectious Diseases 48, 108-114.
33. Heymann SJ (1993) Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 406-411.
34. Hill PC, Rutherford ME, Audas R, Van Crevel R & Graham SM (2011) Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries. PLoS Medicine 8, e1001105.
35. Hirsch-Moverman Y, Tsiouris S, Salazar-Schicchi J et al. (2006) Physician attitudes regarding latent tuberculosis infection: international vs. U.S. medical graduates. The International Journal of Tuberculosis and Lung Disease 10, 1178-1180.
36. Horwood C, Voce A, Vermaak K, Rollins N & Qazi S (2010) Routine checks for HIV in children attending primary health care facilities in South Africa: attitudes of nurses and child caregivers. Social Science and Medicine 70, 313-320.
37. Hsu KHK (1956) Should primary tuberculosis in children continue to be neglected? Journal of Pediatrics 48, 501-519.
38. Hsu KHK (1984) Thirty years after isoniazid. Its impact on tuberculosis in children and adolescents. JAMA 251, 1283-1285.
39. Kenyon TA, Creek T, Laserson K et al. (2002) Risk factors for transmission of Mycobacterium tuberculosis from HIV-infected tuberculosis patients, Botswana. The International Journal of Tuberculosis and Lung Disease 6, 843-850.
40. Kruk A, Gie RP, Schaaf HS & Marais BJ (2008) Symptom-based screening of child tuberculosis contacts: improved feasibility in resource-limited settings. Pediatrics 121, e1646-e1652.
41. Landry J & Menzies D (2008) Preventive chemotherapy. Where has it got us? Where to go next? The International Journal of Tuberculosis and Lung Disease 12, 1352-1364.
42. Lawn SD, Bekker LG, Middelkoop K, Myer L & Wood R (2006) Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clinical Infectious Diseases 42, 1040-1047.
43. Lester R, Hamilton R, Charalambous S et al. (2010) Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS 24 (Suppl. 5), S45-S48.
44. Lienhardt C, Fielding K, Sillah J et al. (2003) Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia. American Journal of Respiratory and Critical Care Medicine 168, 448-455.
45. Lockman S, Tappero JW, Kenyon TA et al. (1999) Tuberculin reactivity in a pediatric population with high BCG vaccination coverage. The International Journal of Tuberculosis and Lung Disease 3, 23-30.
46. Macintyre CR, Plant AJ & Hendrie D (2000) The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis. Health Economics 9, 411-421.
47. Magdorf K, Arizzi-Rusche AF, Geiter LJ et al. (1994) Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood - a pilot project. Pneumologie 48, 761-764.
48. Marais BJ, Gie RP, Schaaf HS et al. (2004) The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. The International Journal of Tuberculosis and Lung Disease 8, 392-402.
49. Marais BJ, Gie RP, Hesseling AC et al. (2006a) Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings. The Pediatric Infectious Disease Journal 25, 237-240.
50. Marais BJ, Van Zyl S, Schaaf HS et al. (2006b) Adherence to isoniazid preventive chemotherapy: a prospective community based study. Archives of Disease in Childhood 91, 762-765.
51. Marais BJ, Graham SM, Cotton MF & Beyers N (2007) Diagnostic and management challenges for childhood tuberculosis in the era of HIV. Journal of Infectious Diseases 196 (Suppl. 1), S76-S85.
52. Marais BJ, Ayles H, Graham SM & Godfrey-Faussett P (2009) Screening and preventive therapy for tuberculosis. Clinics in Chest Medicine 30, 827-846.
53. McElroy PD, Liaz K, Lambert LA et al. (2005) National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection. Clinical Infectious Diseases 41, 1125-1133.
54. Mcilleron H, Willemse M, Werely CJ et al. (2009) Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clinical Infectious Diseases 48, 1547-1553.
55. Mitchison DA (2000) Role of individual drugs in the chemotherapy of tuberculosis. The International Journal of Tuberculosis and Lung Disease 4, 796-806.
56. Nakajo MM, Rao M & Steiner P (1989) Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis. The Pediatric Infectious Disease Journal 8, 649-650.
57. National Tuberculosis Controllers Association, Centers for Disease Control and Prevention (CDC) (2005) Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendation from the National Tuberculosis Controllers Association and CDC. Morbidity and Mortality Weekly Report. Recommendations and Reports 16, 1-47.
58. Nelson LJ & Wells CD (2004) Global epidemiology of childhood tuberculosis. The International Journal of Tuberculosis and Lung Disease 8, 636-647.
59. Nyirenda M, Sinfield R, Haves S, Molyneux EM & Graham SM (2006) Poor attendance at a child TB contact clinic in Malawi. The International Journal of Tuberculosis and Lung Disease 10, 585-587.
60. Ormerod LP & Horsfield N (1996) Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tubercle and Lung Disease 77, 37-42.
61. Padmini R, Srinivasan S, Nalini P & Mahadevan S (1993) Short course chemotherapy for tuberculosis in children. Journal of Tropical Pediatrics 39, 361-364.
62. Priest DH, Vossel LF Jr, Sherfy EA, Hoy DP & Haley CA (2004) Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing program. Clinical Infectious Diseases 39, 1764-1771.
63. Rekha B & Swaminathan S (2007) Childhood tuberculosis - global epidemiology and the impact of HIV. Paediatric Respiratory Reviews 8, 99-106.
64. Rennie TW, Bothamley GH, Engova D & Bates IP (2007) Patient choice promotes adherence in preventive treatment for latent tuberculosis. European Respiratory Journal 30, 728-735.
65. le Roux SM, Cotton MF, Golub JE et al. (2009) Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules. BMC Medicine 7, 67.
66. Rutherford ME, Nataprawira M, Yulita I et al. (2012) QuantiFERON-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case. The International Journal of Tuberculosis and Lung Disease 16, 496-502.
67. Salleras Sanmarti L, Alcaide Megias J, Altet Gomez MN et al. (1993) Evaluation of the efficacy of health education on the compliance with antituberculosis chemoprophylaxis in school children. A randomized clinical trial. Tubercle and Lung Disease 74, 28-31.
68. Samandari T, Bishai D, Luteijn M et al. (2011) Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana. American Journal of Respiratory and Critical Care Medicine 183, 1103-1111.
69. Schaaf HS & Marais BJ (2011) Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians. Paediatric Respiratory Reviews 12, 31-38.
70. Schaaf HS, Gie RP, Kennedy M et al. (2002) Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics 109, 765-771.
71. Sinfield R, Nyirenda M, Haves S, Molyneux EM & Graham SM (2006) Risk factors for TB infection and disease in young childhood contacts in Malawi. Annals of Tropical Paediatrics 26, 205-213.
72. Sneag DB, Schaaf HS, Cotton MF & Zar HJ (2007) Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. The Pediatric Infectious Disease Journal 26, 1142-1146.
73. Spyridis P, Sinaniotis C, Papadea I et al. (1979) Isoniazid liver injury during chemoprophylaxis in children. Archives of Disease in Childhood 54, 65-67.
74. Spyridis NP, Spyridis PG, Gelesme A et al. (2007) The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clinical Infectious Diseases 45, 715-722.
75. Sterling TR, Villarino ME, Borisov AS et al. (2011) Three months of rifapentine and isoniazid for latent tuberculosis infection. New England Journal of Medicine 365, 2155-2166.
76. Tochon M, Bosdure E, Salles M et al. (2011) Management of young children in contact with an adult with drug-resistant tuberculosis, France 2004-2008. The International Journal of Tuberculosis and Lung Disease 15, 326-330.
77. Tornee S, Kaewkungwal J, Fungladda W et al. (2005) Factors associated with the household contact screening adherence of tuberculosis patients. Southeast Asian Journal of Tropical Medicine and Public Health 36, 331-340.
78. Trajman A, Long R, Zylberberg D et al. (2010) Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. The International Journal of Tuberculosis and Lung Disease 14, 551-559.
79. Triasih R, Rutherford M, Lestari T et al. (2012) Contact investigation of children exposed to tuberculosis in South East Asia: a systematic review. Journal of Tropical Medicine 2012, 301808.
80. Van Zyl S, Marais BJ, Hesseling AC et al. (2006) Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. The International Journal of Tuberculosis and Lung Disease 10, 13-18.
81. Whalen CC, Johnson JL, Okwera A et al. (1997) A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-case Western Reserve University Research Collaboration. New England Journal of Medicine 337, 801-808.
82. WHO (2006a) Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. WHO, Geneva.
83. WHO (2006b) Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. Stop TB Partnership Childhood TB Subgroup World Health Orgainzation, Geneva.
84. WHO (2010a) The Global Plan to Stop TB 2011-2015; Transforming the Fight Towards Elimination of Tuberculosis. WHO, Geneva.
85. WHO (2010b) Guidance for National Tuberculosis and HIV Programmes on the Management of Tuberculosis in HIV-Infected Children: Recommendations for a Public Health Approach (ed. WA Iuatld). WHO, Geneva.
86. WHO (2010c) Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living with HIV in Resource-Constrained Settings. WHO, Geneva.
87. WHO (2010d) Rapid Advice: Treatment of Tuberculosis in Children. WHO, Geneva.
88. WHO (2012) Global drug facility. http://wwwstoptb.org/gdf/(accessed 20 June 2012).
89. Zachariah R, Spielmann MP, Harries AD et al. (2003) Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. The International Journal of Tuberculosis and Lung Disease 7, 1033-1039.